Pancreatic Cancer

Pancreatic Cancer Trials Don’t Adhere to Eligibility Criteria Guidelines

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 9, 2023

Overall compliance with eligibility criteria guidelines is low for pancreatic cancer trials, a recent study suggests.

Cancer Patients in Nursing Homes More Likely to Receive Aggressive End-of-Life Care

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date March 8, 2023

Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.

Incidence of Pancreatic Cancer Increasing in Younger Women

Publish Date February 24, 2023

Difference in average annual percentage change due to increasing incidence in Blacks, adenocarcinoma histopathological subtype, tumor location.

Precision Medicine Can Be Integrated Into Routine Cancer Care

Publish Date February 13, 2023

Implementation of precision oncology recommendations has clinical utility for patients with gastrointestinal cancers.

Adjuvant Therapy Benefits Pancreatic Adenocarcinoma After Neoadjuvant Therapy, Resection

By

Vicki Moore, PhD

Publish Date December 13, 2022

A retrospective review of records revealed a possible survival benefit for patients with PDAC treated with adjuvant therapy and surgery.

Pancreatic Cancer Clinical Trials

Clinical Trial: BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Clinical Trial: Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Clinical Trial: Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

Clinical Trial: Studying Biomarkers in Patients With Pancreatic Cancer

Clinical Trial:A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer